热门资讯> 正文
ING、Pali和FNCH均为上市前输家
2024-04-24 20:45
- Losers: Evotec SE (EVO) -31% reports FY results
- Finch Therapeutics Group (FNCH) -14%.
- NKGen Biotech (NKGN) -14%.
- HWH International (HWH) -13%.
- Neo-Concept International Group Holdings Ltd. (NCI) -12%.
- SILO Pharma (SILO) -9%.
- AGBA Group Holding Limited (AGBA) -9%.
- Equinox Gold Corp (EQX) -8% buys rest of Greenstone gold mine in $995M cash and stock deal.
- Enphase Energy (ENPH) -7% after Q1 earnings release.
- ING Groep N.V. (ING) -6%.
- Zhongchao (ZCMD) -6%.
- Cazoo Group Ltd (CZOO) -6%.
- Palisade Bio (PALI) -5%.
More on pre-market losers & stocks.
- ING: Still Too Cheap Despite Disappointing Results
- ING Groep NV (ING) Q4 2023 Earnings Call Transcript
- Palisade Bio stock rallies nearly 100% on colitis drug analysis
- Palisade Bio stock slides 8% amid colitis drug presentation
- Financial information for Finch Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
